Sfoglia per Autore
1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable?
2019-01-01 Mccusker, M G; Russo, A; Chen, J; Scilla, K A; Mehra, R; Rolfo, C D
Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC
2019-01-01 Russo, Alessandro; Ron, David Arias; Rasschaert, Marika; Prenen, Hans; Mehra, Ranee; Scilla, Katherine; Pauwels, Patrick; Rolfo, Christian
How I treat ALK-positive non-small cell lung cancer
2019-01-01 Mccusker, Michael G; Russo, Alessandro; Scilla, Katherine A; Mehra, Ranee; Rolfo, Christian
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario
2019-01-01 Rossi, Giovanni; Pezzuto, Aldo; Sini, Claudio; Tuzi, Alessandro; Citarella, Fabrizio; Mccusker, Michael G.; Nigro, Olga; Tanda, Enrica; Russo, Alessandro
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario
2019-01-01 Russo, A.; Franchina, T.; Ricciardi, G.; Battaglia, A.; Picciotto, M.; Adamo, V.
Liquid biopsy tracking of lung tumor evolutions over time
2019-01-01 Russo, A.; De Miguel Perez, D.; Gunasekaran, M.; Scilla, K.; Lapidus, R.; Cooper, B.; Mehra, R.; Adamo, V.; Malapelle, U.; Rolfo, C.
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
2019-01-01 Singhal, Sandeep; Rolfo, Christian; Maksymiuk, Andrew W; Tappia, Paramjit S; Sitar, Daniel S; Russo, Alessandro; Akhtar, Parveen S; Khatun, Nazrina; Rahnuma, Parveen; Rashiduzzaman, Ahmed; Ahmed Bux, Rashid; Huang, Guoyu; Ramjiawan, Bram
Exosomal PD-L1 expression and dynamic changes of immune response associated cytokines as predictive biomarkers for immune checkpoint blockage with PD-1/PD-L1 inhibitors in advanced/metastatic non-small cell lung cancer
2019-10-30 Russo, Alessandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? | 1-gen-2019 | Mccusker, M G; Russo, A; Chen, J; Scilla, K A; Mehra, R; Rolfo, C D | |
| Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC | 1-gen-2019 | Russo, Alessandro; Ron, David Arias; Rasschaert, Marika; Prenen, Hans; Mehra, Ranee; Scilla, Katherine; Pauwels, Patrick; Rolfo, Christian | |
| How I treat ALK-positive non-small cell lung cancer | 1-gen-2019 | Mccusker, Michael G; Russo, Alessandro; Scilla, Katherine A; Mehra, Ranee; Rolfo, Christian | |
| Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario | 1-gen-2019 | Rossi, Giovanni; Pezzuto, Aldo; Sini, Claudio; Tuzi, Alessandro; Citarella, Fabrizio; Mccusker, Michael G.; Nigro, Olga; Tanda, Enrica; Russo, Alessandro | |
| Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario | 1-gen-2019 | Russo, A.; Franchina, T.; Ricciardi, G.; Battaglia, A.; Picciotto, M.; Adamo, V. | |
| Liquid biopsy tracking of lung tumor evolutions over time | 1-gen-2019 | Russo, A.; De Miguel Perez, D.; Gunasekaran, M.; Scilla, K.; Lapidus, R.; Cooper, B.; Mehra, R.; Adamo, V.; Malapelle, U.; Rolfo, C. | |
| Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study | 1-gen-2019 | Singhal, Sandeep; Rolfo, Christian; Maksymiuk, Andrew W; Tappia, Paramjit S; Sitar, Daniel S; Russo, Alessandro; Akhtar, Parveen S; Khatun, Nazrina; Rahnuma, Parveen; Rashiduzzaman, Ahmed; Ahmed Bux, Rashid; Huang, Guoyu; Ramjiawan, Bram | |
| Exosomal PD-L1 expression and dynamic changes of immune response associated cytokines as predictive biomarkers for immune checkpoint blockage with PD-1/PD-L1 inhibitors in advanced/metastatic non-small cell lung cancer | 30-ott-2019 | Russo, Alessandro |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile